II
BLUE

Inspire Investing’s bluebird bio BLUE Stock Holding History

Inspire Investing’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,525
Closed -$209K – 765
2022
Q2 		$209K Buy
2,525
+89
+4% +$6.9K 0.03% 754
2022
Q1 		$236K Buy
2,436
+1,204
+98% +$159K 0.03% 473
2021
Q4 		$246K Buy
1,232
+254
+26% +$59.9K 0.03% 694
2021
Q3 		$242K Buy
+978
New +$280K 0.03% 379
2020
Q2 		– Hold
0
– – – 523
2020
Q1 		– Hold
0
– – – 745
2018
Q1 		– Sell
-25
Closed -$57K – 264
2017
Q4 		$57K Buy
+25
New +$50.8K 0.05% 451

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Inspire Investing's BLUE Position: Q3 2022 in Review

Inspire Investing sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 2,525 shares — an estimated $209K sold.

Inspire Investing first reported a position in BLUE in Q4 2017 and held it in 5 quarters. The position peaked at $246K in Q4 2021. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

  • Inspire Investing reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
  • Inspire Investing sold 2,525 bluebird bio shares in Q3 2022, an estimated $209K.
  • Inspire Investing first reported a position in bluebird bio in Q4 2017 and held it in 5 quarters.
  • Inspire Investing's bluebird bio position peaked at $246K in Q4 2021.
  • 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Inspire Investing's 13F filing for Q3 2022, filed 7 Nov 2022.